PDCD1 and neoplasm: Lee et al. [60] identified that S100A14 inhibits STAT3-mediated PD-1 expression and the phenotype of tumor stem cells, promotes CD8+ T-cell-mediated cytotoxicity, inhibits immune evasion, and restores chemosensitivity.